Roxybond Tablet, Coated
Product Images NDC 81140-101

This appears to be a chart or graph with measurements of drug liking VAS (visual analog scale) ranging from 0 to 80 over a span of 24 hours in relation to different types of oxycodone administration. The chart includes measurements for crushed intranasal oxycodone immediate-release tablets, crushed intranasal ROXYBOND, intact oral ROXYBOND, and a placebo. However, there is not enough information to provide further details or conclusions.*

Each tablet with the identification code "IDT/0 5" contains 5 mg of oxycodone hydrochloride. These tablets, marketed under the brand name RoxyBond™, are indicated for the management of pain severe enough to require an opioid analgesic. The package insert provides complete prescribing information. The tablets should be stored at a temperature range of 15°-30°C (59°-86°F), protected from moisture, in a well-closed container with a child-resistant closure. The National Drug Code (NDC) for the package containing 100 tablets is 81140-101-10. The manufacturer of RoxyBond™ tablets is Protega Pharmaceuticals, LLC, based in Princeton, NJ.*

Each tablet contains 15mg of oxycodone hydrochloride, and this medication is intended for prescription-only dispensation. Patients who receive this medication must be given a medication guide together with this drug. Also, these Oxycodone hydrochloride tablets should be stored in a well-closed container at room temperature between 15° and 30°C. It's important to keep the tablets out of the reach of children and safe from moisture. These tablets are manufactured for Protega Pharmaceuticals LLC, located in Princeton, NJ 08540. For complete prescribing information, interested parties should refer to the package insert.*

Each tablet contains 30mg of Oxycodone Hydrochloride, which is equivalent to 30mg of OxyCodone. The tablets come in a pack of 100 with an identification code. The tablets should be stored at a temperature of 25°C (77°F) with permitted excursions of 15°C to 30°C (59°F to 86°F) as per USP controlled room temperature. The tablets should not be used unless identified. A medication guide needs to accompany the tablets to protect from moisture. The tablets must be dispensed with a child-resistant closure in a well-closed container. This medication is manufactured for Protega Pharmaceuticals, LLC based in Princeton, NJ. For detailed prescribing information, please refer to the package insert.*